Biciromab is a monoclonal antibody that targets fibrin II beta chain, brin. Fibrin is a protein involved in the clotting of blood. Biciromab could label with the radioisotope indium-111 for the diagnosis of thromboembolism.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.